Why is Samrat Pharmachem Ltd ?
1
Weak Long Term Fundamental Strength with a -170.13% CAGR growth in Operating Profits over the last 5 years
2
Flat results in Sep 26
- INVENTORY TURNOVER RATIO(HY) Lowest at 5.58 times
- NET SALES(Q) At Rs 66.01 cr has Fallen at -10.1% (vs previous 4Q average)
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -18.55%, its profits have fallen by -175.6%
4
Below par performance in long term as well as near term
- Along with generating -18.55% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Samrat Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Samrat Pharma
-18.55%
-0.35
53.61%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
6.14%
EBIT Growth (5y)
-170.13%
EBIT to Interest (avg)
10.08
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
3.70
Tax Ratio
44.44%
Dividend Payout Ratio
4.34%
Pledged Shares
0
Institutional Holding
3.24%
ROCE (avg)
16.60%
ROE (avg)
12.12%
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
40
Price to Book Value
0.99
EV to EBIT
-49.61
EV to EBITDA
-79.37
EV to Capital Employed
0.99
EV to Sales
0.28
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-2.00%
ROE (Latest)
-1.70%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
Technical Movement
6What is working for the Company
PAT(Latest six months)
Higher at Rs 1.32 cr
-4What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 5.58 times
NET SALES(Q)
At Rs 66.01 cr has Fallen at -10.1% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is working for Samrat Pharma
Profit After Tax (PAT) - Latest six months
At Rs 1.32 cr has Grown at 260.98%
Year on Year (YoY)MOJO Watch
PAT trend is very positive
PAT (Rs Cr)
Profit After Tax (PAT) - Latest six months
Higher at Rs 1.32 cr
than preceding 12 month period ended Sep 2026 of Rs -3.32 crMOJO Watch
In the half year the company has already crossed PAT of the previous twelve months
PAT (Rs Cr)
Here's what is not working for Samrat Pharma
Net Sales - Quarterly
At Rs 66.01 cr has Fallen at -10.1% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 73.46 CrMOJO Watch
Near term sales trend is very negative
Net Sales (Rs Cr)
Inventory Turnover Ratio- Half Yearly
Lowest at 5.58 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio